Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lexicon Genetics identifies new target for obesity drug development

June 12, 2002

ActivX and Kyorin enter drug discovery collaboration in type 2 diabetes

June 12, 2002

New 5-HT6 antagonists for obesity and CNS disorders

June 12, 2002

Merck & Co. revises Zocor prescribing information

June 11, 2002

Successful in vivo gene therapy of Gaucher's disease discussed at ASGT meeting

June 11, 2002

Hemosol revises timetable for Hemolink

June 11, 2002

PPARgamma ligands for use in obesity, bone diseases, lipoprotein disorders, etc.

June 11, 2002

Oxford BioMedica adds Repoxygen for anemia to development portfolio

June 10, 2002

Neuropeptide Y ligands identified at Servier

June 10, 2002

FDA issues approvable letter for Crestor

June 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...